KALISPELL, Mont. - eTradeWire -- GoTo Telemed, the nation's leading integrated telehealth ecosystem serving over 10 million patients nationwide, today announced the launch of its dedicated Dyslipidemia Management Program, a comprehensive virtual care service designed to achieve and sustain aggressive guideline‑directed lipid targets through remote pharmacist‑led medication management, structured telehealth follow‑up, and integrated cardiovascular risk monitoring.

Dyslipidemia is a leading risk factor for atherosclerotic cardiovascular disease (ASCVD), the most common cause of preventable death in the industrialised world. Current AHA/ACC guidelines recommend high‑intensity statin (HIS) therapy with stepwise addition of ezetimibe, PCSK9 inhibitors and other lipid‑lowering agents (LLTs) to achieve LDL‑C <55 mg/dL for very high‑risk patients and <70 mg/dL for high‑risk patients. Yet real‑world achievement of these targets remains suboptimal, especially in underserved populations, due to barriers in follow‑up, medication adherence and access to advanced LLTs. GoTo Telemed's program directly overcomes these obstacles by embedding a Pharm.D.‑led virtual clinic and remote biomarker monitoring within a unified telehealth platform.

More on eTradeWire News

• LKPFM corporation understanding a winch
• Squatch51 Launches Signature Series – 12 Cosmic Coffees Now Available
• Detroit Philanthropy Industry Networking Event - June 17
• Longevity Academy Launches The Longevity Leaders Project with Interview of Respira Global CEO
• 11th Annual Sergeant Ron Helus Ride for the Blue Returns May 30

"Lipid management is a cornerstone of cardiovascular prevention, yet countless patients remain at risk because they fail to achieve the aggressive LDL‑C targets that modern therapy can deliver," said a GoTo Telemed spokesperson. "Our Dyslipidemia Management Program closes the evidence–practice gap through a scalable, virtual, pharmacist‑driven model. Patients receive structured remote follow‑up, algorithmic medication titration, and continuous performance monitoring—all without the need for repeated in‑person visits."
The program leverages algorithm‑guided remote monitoring technology that has demonstrated improved health equity in both hypertension and cholesterol management. Pharmacists, guided by electronic medical record (EMR) tools and evidence‑based protocols, initiate and titrate medications to guideline‑directed targets. Using digitally connected home blood pressure monitors and laboratory‑coordinated lipid panels, the platform transmits physiologic and lipid data directly to the patient's electronic health record, enabling real‑time, data‑driven treatment adjustments.

More on eTradeWire News

• Rocky Mountain Photography Expands Commercial Drone and Video Production Services Across Denver
• Virginia Marchese's Paradox: A Nation Still Deciding Who Belongs Examines Race, Migration, Law, and America's Unfinished Struggle for Equality
• From Blank Page to Published Book
• Larry R. Wasion's Jump Gate III RoadMaker Blends Cutting-Edge Sci-Fi with High-Stakes Space Exploration and Complex Technologies
• 47 States Complete, 3 States Remain : Man on Historic 50 State Trek reaches Oregon

In a large health‑system study of over 10,000 patients, this remote, algorithm‑driven approach achieved a 50% reduction in LDL‑C (from 140 mg/dL to 70 mg/dL) in those who reached a guideline‑recommended lipid‑lowering regimen. Telehealth is increasingly recognised as a crucial tool to improve lipid management, especially for patients in rural or medically underserved areas.

Media Contact:
GoTo Telemed Media Relations
info@gototelemed.com
(660) 628-1660
https://gototelemed.com/